Free Republic

Weeks ago a study claiming that the antimalarial drug hydroxychloroquine was linked to higher rates of mortality with coronavirus patients was based on possibly bogus data from a small America-based company called Surgisphere, reports The Guardian. The World Health Organization and many national governments changed their policies and treatment guidelines based on this faulty study. Many in the media freaked out when Trump revealed he was taking the drug to protect him from the coronavirus. A Guardian investigation can reveal the US-based company Surgisphere, whose handful of employees appear to include a science fiction writer and an adult-content model, has...

Paris (AFP) - Dozens of scientists have raised concerns over a large-scale study of hydroxychloroquine and chloroquine published in the Lancet that led to the World Health Organization suspending clinical trials of the anti-viral drugs as a potential treatment for COVID-19. Hydroxychloroquine, normally used to treat arthritis, has become one of the most high profile drugs being tested for use against the new coronavirus. This is partly because of comments by public figures including US President Donald Trump, who announced this month he was taking the drug as a preventative measure. In research published in the Lancet on May 22,...

Oncologist and hematologist Dr. William Grace joins Laura Ingraham with reaction on 'The Ingraham Angle.' ( CLICK ABOVE LINK FOR THE VIDEO ). See the study here. TITLE: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis Authored by Dr. Harvey Risch at the American Journal of Epidemiology. Abstract More than 1.6 million Americans have been infected with SARS-CoV-2 and >10 times that number carry antibodies to it. High-risk patients presenting with progressing symptomatic disease have only hospitalization treatment with its high mortality. An outpatient treatment that prevents hospitalization is...

Questions have been raised by Australian infectious disease researchers about a study published in the Lancet which prompted the World Health Organization to halt global trials of the drug hydroxychloroquine to treat Covid-19. The study published on Friday found Covid-19 patients who received the malaria drug were dying at higher rates and experiencing more heart-related complications than other virus patients. The large observational study analysed data from nearly 15,000 patients with Covid-19 who received the drug alone or in combination with antibiotics, comparing this data with 81,000 controls who did not receive the drug. The findings prompted researchers from around...

Chloroquine and hydroxychloroquine offer no clinical benefit for people with COVID-19 and might cause serious heart-related side effects, according to a study published Friday in The Lancet. People with severe illness caused by the new coronavirus, SARS-CoV-2, treated with either drug -- either alone or with an antiviral medication -- were up to twice as likely to die than those in the control group, which received standard, supportive care, the researchers found. Those who died did so either as a result of COVID-19 or from side effects from treatment, the authors said. "This is the first large-scale study to find...

A medical institute in Australia will administer a trial at hospitals across the country to determine if the anti-malaria drug hydroxychloroquine can prevent the spread of coronavirus. The Walter and Eliza Hall Institute of Medical Research is spearheading the study on frontline workers in an effort to find a preventative measure to stop the spread of the virus. “The trial is focused on our frontline and allied healthcare workers who are at an increased risk of infection due to repeated exposure caring for sick patients,” said Professor Ian Wicks, joint head of clinical translation at the Institute.

The antimalarial drug candidate for coronavirus has long been introduced as a 'game-changer' in treating COVID-19 patients. However, in recent studies, contrasting results have been seen in patients. Some claim to have improved their condition with the help of the drug, while others blame the cure for the adverse reactions it brings. A new study from New York suggests that the drug may yield better results when used in combination with the dietary supplement, zinc. Researchers from the NYU Grossman School of Medicine placed a medical preprint on their site on Monday. Their paper is yet to be peer-reviewed. In...

The politicization of hydroxychloroquine has been one of the most frustrating aspects of Trump Derangement Syndrome during this pandemic. Early studies in France and clinical outcomes from multiple treating physicians using a combination therapy that included the drug provided hope to combat the virus. However, it made President Trump hopeful, so it had to be obliterated. Crappy studies of the drug given to the most severe patients were touted as proof the president was wrong. Then there was Fish Tank Cleaner Gate. This is the problem with political reporters covering press briefings about a pandemic. They either aren’t provided an...

The antimalarial drug hydroxychloroquine has shown mixed results against the coronavirus in early studies, but a new paper out of New York suggests combining it with the dietary supplement zinc sulfate could create a more effective treatment. The research by the NYU Grossman School of Medicine was posted on a medical preprint site on Monday, meaning it hasn't yet been peer reviewed. Records of about 900 COVID-19 patients were reviewed in the analysis, with roughly half given zinc sulfate along with hydroxychloroquine and the antibiotic azithromycin. The other half only received hydroxychloroquine and azithromycin. Those receiving the triple-drug combination had...

COVID-19 damages the hemoglobin, impairing the ability of red blood cells to transport oxygen throughout the body, compromising the lungs and resulting in Acute Respiratory Distress Syndrome (ARDS), Italian pharmacology scholar Annalisa Chiusolo explained to The Jerusalem Post. If her thesis is correct, it would resolve many outstanding questions about the novel coronavirus, such as the greater vulnerability of men – specifically male diabetics – to become seriously ill from the virus, as well as the lower rate at which pregnant women and children contract COVID-19. Moreover, understanding this mechanism could lead the way to a quicker discovery of the...

As some Western studies found hydroxychloroquine ineffective as a potential Covid-19 therapy, a new Chinese research has reported that the anti-malarial drug brought down mortality rates significantly among critical coronavirus patients. The latest preprint study -- which means it's not yet peer-reviewed -- is based on the clinical analysis of 568 Covid-19 cases at Tongji Hospital in Wuhan, the initial epicentre of the pandemic, between February 1 and April 8. Funded by China's Ministry of Science and Technology, Nature Science Foundation and Ma Yun Foundation, the research is sent to the Science China Life Sciences journal for peer-reviewing. According to...

"I am a doctor and, positive for Covid19 , I immediately took hydroxychloroquine : in 3-4 days the fever and the other symptoms disappeared ". This is how Paola Varese , head of cancer medicine at the Ovada hospital in Piedmont , begins . "I applied the same protocol on myself that I planned for 276 patients at home," continues Varese , stressing that "timely intervention by family doctors in patients' homes is essential, with hydroxychloroquine associated with heparin (and if necessary the ' antibiotic ). It is presumable - he says - that the collapse of thehospitalization is due...

UCLA is one of seven sites participating in a clinical trial investigating whether hydroxychloroquine, a commonly used anti-malarial and autoimmune drug, can prevent infection with COVID-19. The multi-site study led by the University of Washington in collaboration with six other university centers, is now enrolling 2,000 participants who are close contacts of persons who are confirmed or suspected to be infected with COVID-19. The aim is to determine whether hydroxychloroquine can prevent infection in people exposed to the virus. "There has been a lot of speculation as to whether hydroxychloroquine can treat or prevent COVID-19," said Dr. Raphael J. Landovitz,...

Introduction We are currently facing a pandemic involving a newly discovered coronavirus (SARS-CoV-2) which putting our societies to the test in many ways. Despite controversy, only two drugs, namely hydroxychloroquine (HCQ) and chloroquine (CQ), have been used by physicians on a large-scale basis as treatment forCOVID-19 [1]. According to the Sermo Real Time Covid-19 Barometer (https://www.sermo.com/, consulted 20 April), for over 20,000 physicians across 30 countries, chloroquine derivatives are the first medication used to treat COVID-19 patients in ICUs (67%), the second medication in other hospital settings (66%),and the third in outpatient settings (40%). While many countries recommend it for...

TUSCON, Ariz., April 28, 2020 (GLOBE NEWSWIRE) -- In a letter to Gov. Doug Ducey of Arizona, the Association of American Physicians and Surgeons (AAPS) presents a frequently updated table of studies that report results of treating COVID-19 with the anti-malaria drugs chloroquine (CQ) and hydroxychloroquine (HCQ, Plaquenil®). To date, the total number of reported patients treated with HCQ, with or without zinc and the widely used antibiotic azithromycin, is 2,333, writes AAPS, in observational data from China, France, South Korea, Algeria, and the U.S. Of these, 2,137 or 91.6 percent improved clinically. There were 63 deaths, all but 11...

BALTIMORE, MD -- Researchers at the University of Maryland School of Medicine (UMSOM) have begun testing the effectiveness of hydroxychloroquine as a therapy to prevent infection and symptoms in individuals who have been exposed to COVID-19-positive individuals. The trial is significant because it focuses on preventing COVID-19 and does not involve individuals who are ill with infection but rather healthy individuals who have been exposed. The research is part of a national study being conducted across the COVID-19 Therapeutics Accelerator, an initiative launched by the Bill & Melinda Gates Foundation (BMGF), Wellcome, and Mastercard, with funding from an array of...

Infectious disease expert Dr. Stephen Smith told "The Ingraham Angle" Monday night that a study published last week indicating the antimalarial drug hydroxychloroquine showed no benefit for coronavirus patients in U.S. veterans hospitals was a "sham." "I've no idea why [University of Virginia School of Medicine opthamology professor Dr. Jayakrishna Ambati] delved into this study, which isn't a study. It's a sham," Smith said. "I can't believe anyone took this seriously. There's not one dosage listed, cumulative or daily, of hydroxychloriquine or anthromicin. And people call this a study." The research, which was published in the medRxiv online depository and...

On Tuesday, the results of a study on the benefits of hydroxychloroquine as a treatment for the coronavirus were released. The study analyzed the impact of hydroxychloroquine with and without the antibiotic azithromycin and compared that to patients receiving standard care. The study found there were "more deaths" among those given hydroxychloroquine than those who just received standard care.As you could expect, the media pounced on the study. The Washington Post,  CNN, Salon, TIME Magazine, and plenty of others were just itching to claim that Trump had been wrong or even irresponsible for touting hydroxychloroquine in the first place....

The results of clinical trials are making their way to publication showing hydroxychloroquine to be effective in many, although possibly not all, situations. The American media is silent on these studies. The results of clinical trials are making their way to publication showing hydroxychloroquine to be effective in many, although possibly not all, situations. The American media is silent on these studies. Instead, the American media headline a non-experimental and biased study showing the drug to be ineffective and, even, a cause of death. The non-experimental study concerns a large number of COVID-19 patients (sample size 368) at Veterans Administration...

This week the Washington Post published a study that made the media downright giddy. A study on Veterans Affairs patients concluded that hydroxychloroquine was not all it's cracked up to be, as more COVID-19 patients died on the drug than not.  “An association of increased overall mortality was identified in patients treated with hydroxychloroquine alone,” the study concluded. “These findings highlight the importance of awaiting the results of ongoing prospective, randomized, controlled studies before widespread adoption of these drugs.”The reason so many reporters jumped on the study and confronted the White House task force with it, is because President Trump...